Skip to main content
Clinical Trials/NCT05863117
NCT05863117
Recruiting
Not Applicable

Syphilis and HIV Point of Care Testing (POCT) to Improve Access to Testing Among Inner City, Remote, Rural and Hard to Reach Populations in Saskatchewan

Wellness Wheel Medical Clinic2 sites in 1 country1,650 target enrollmentFebruary 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Syphilis
Sponsor
Wellness Wheel Medical Clinic
Enrollment
1650
Locations
2
Primary Endpoint
Syphilis-Comparison between point of care testing and serology testing for Syphilis and HIV
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to learn about Syphilis and HIV point of care testing among inner city, remote, rural and hard to reach populations in Saskatchewan. The main question[s] it aims to answer are:

  1. To evaluate the field diagnostic test performance (e.g. sensitivity, specificity, predictive values) of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT, HIV POCT and dual syphilis and HIV POCT.

  2. To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically:

    1. Time to diagnosis
    2. Time to treatment
    3. Number of contacts exposed to untreated infections
    4. For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV
  3. To evaluate the acceptability and feasibility of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically:

    1. Health care provider experiences of feasibility and acceptability of the POCT used in this pilot
    2. Client acceptability and experiences with POCT in this pilot
    3. Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis 4. To evaluate the acceptability and feasibility of syphilis alone, HIV alone or combined syphilis/HIV POCT among at-risk and/or hard to reach populations.

Participants will be assessed for risk factors that may increase risk of infectious disease such as substance use and sexual habits. They will then be offered a choice of 1 of 3 POCT(Syphilis alone, HIV alone or a dual HIV/Syphilis test). Serology will be obtained for sexually transmitted and blood born infections (STBBI's) and then the point of care test (POCT) will be completed. Following the testing the participant will complete a short survey on their experience.

Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
July 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Wellness Wheel Medical Clinic
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 1650 consecutive individuals
  • \> 16 years accessing STBBI testing at specific locations and able to provide informed consent. PLWH and persons who are syphilis positive may also eligible to participate.

Exclusion Criteria

  • ° Less than 16 years, unable to provide signed informed consent (e.g., intoxicated)

Outcomes

Primary Outcomes

Syphilis-Comparison between point of care testing and serology testing for Syphilis and HIV

Time Frame: 12-18 months

To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT.

Syphilis/HIV- Comparison between point of care testing and serology testing for Syphilis and HIV

Time Frame: 12-18 months

Dual HIV/Syphilis-To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for dual syphilis and HIV POCT.

HIV- Comparison between point of care testing and serology testing for Syphilis and HIV

Time Frame: 12-18 months

HIV- To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for HIV POCT.

Secondary Outcomes

  • Time to diagnosis-Clinical utility of POCT for management and follow up of Syphilis and HIV(12-18 months)
  • Evaluate the acceptability and feasibility of POCT for syphilis and HIV(12-18 months)
  • Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.(12-18 months)
  • Number of contacts-Clinical utility of POCT for management and follow up of Syphilis and HIV(12-18 months)
  • Dual HIV/Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.(12-18 months)
  • HIV-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.(12-18 months)
  • Time to treatment-Clinical utility of POCT for management and follow up of Syphilis and HIV(12-18 months)
  • Time to connection-Clinical utility of POCT for management and follow up of Syphilis and HIV(12-18 months)

Study Sites (2)

Loading locations...

Similar Trials